Nanopublication

< Home

ID

http://purl.org/np/RASkp2LUV60Mbco-iKCPIz0UYNOx9fPtb7XLbwUu5kKbE

Formats

.trig | .trig.txt | .jelly | .jelly.txt

Content

@prefix this: <http://purl.org/np/RASkp2LUV60Mbco-iKCPIz0UYNOx9fPtb7XLbwUu5kKbE> .
@prefix sub: <http://purl.org/np/RASkp2LUV60Mbco-iKCPIz0UYNOx9fPtb7XLbwUu5kKbE#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix pav: <http://purl.org/pav/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix umls: <http://identifiers.org/umls/> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .

sub:Head {
  this: a np:Nanopublication;
    np:hasAssertion sub:assertion;
    np:hasProvenance sub:provenance;
    np:hasPublicationInfo sub:pubInfo .
}

sub:assertion {
  <http://identifiers.org/pubchem.compound/54674461> a biolink:ChemicalEntity;
    rdfs:label "Vericiguat";
    biolink:category biolink:ChemicalEntity .
  
  umls:C4707345 a biolink:DiseaseOrPhenotypicFeature;
    rdfs:label "cardiovascular death";
    biolink:category biolink:DiseaseOrPhenotypicFeature .
  
  <http://purl.obolibrary.org/obo/MONDO_0005009> a biolink:DiseaseOrPhenotypicFeature;
    rdfs:label "heart failure";
    biolink:category biolink:DiseaseOrPhenotypicFeature .
  
  sub:_1 a biolink:Association;
    rdf:object <http://purl.obolibrary.org/obo/MONDO_0005009>;
    rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/pubchem.compound/54674461>;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94b996dc-ddc4-41ce-9a9f-3d91cb187473> .
  
  sub:_2 a biolink:Association;
    rdf:object umls:C4707345;
    rdf:predicate biolink:treats;
    rdf:subject <http://identifiers.org/pubchem.compound/54674461>;
    biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
    biolink:category biolink:Association;
    biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=94b996dc-ddc4-41ce-9a9f-3d91cb187473> .
}

sub:provenance {
  sub:assertion prov:generatedAtTime "2022-10-13T12:49:16.653528"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-3668-2627;
    prov:wasQuotedFrom " Vericiguat is indicated in adults with symptomatic, chronic heart failure and an ejection fraction of <45%. It is indicated to reduce the risk of cardiovascular death and heart failure-related hospitalization following a hospitalization for heart failure or need for outpatient intravenous diuretics. It reduces cardiovascular death, heart failure related hospitalization, and hospitalization associated with heart failure." .
  
  biolink: pav:version "2.3.0" .
}

sub:pubInfo {
  sub:sig npx:hasAlgorithm "RSA";
    npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB";
    npx:hasSignature "NeM7mkjXRerJBlvIcY0zMJKN4BAXVWb3IpLHBpiGDmj9bNewdqtscO79XJaBYOVpp+jbhv6N/LC7jEIxRGhG1pGRZJ9o5AIGOEZi2LYCLZcczXhN5IuaW3l53CkFfdewodhZy/OSyt9G9ldvoSjBMN5IsV+b6Yr22/GuY9CDOy+qslnLgXJgY886Rry6pdPIJ7iykNRbzona6nuRM/hiZjcw7OxXCQ8x4C5+eA+p7gFzTA1HIegDQhY3O3X3eUeIqVFTsBaxTn6LYcLrL5EV1wuwuQAItNqxb00t5frA3ba+4eJPZrpVMqNTNMgl3VHrviX8unOTCfb7g+qLnE1sZw==";
    npx:hasSignatureTarget this: .
  
  this: prov:generatedAtTime "2022-10-13T12:49:16.653528"^^xsd:dateTime;
    prov:wasAttributedTo orcid:0000-0002-3668-2627 .
}